13 April 2022
Hill & Smith Holdings PLC
CORRECTION: Director/PDMR Shareholding
The following amendment has been made to the "Director/PDMR shareholding" announcement released on 12 April 2022 at 08.40 under RNS No 0997I
In section 4 (d) of the PDMR form this should read Price '£14.4069' not 'Price £1440.69' as previously stated.
As a result of this purchase Mr Farrokh Batliwala has a beneficial interest in 2,000 shares in Hill & Smith Holdings PLC at a value of £28,813.80.
All other details remain unchanged.
Director/PDMR Shareholding
Hill & Smith Holdings PLC ('Hill & Smith' or 'the Company') announces that it has been notified that Farrokh Batliwala, Non-executive Director of Hill & Smith, has purchased 2,000 ordinary shares in the Company ('Ordinary Shares').
As a result of this transaction, Mr Batliwala now has a beneficial interest in 2,000 Ordinary Shares.
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
|
(a) |
Name |
Farrokh Batliwala |
||||
|
2. |
Reason for the notification |
|||||
|
(a) |
Position/status |
Non-executive Director |
||||
|
(b) |
Initial notification/ Amendment |
Initial notification |
||||
|
3. |
Details of the issuer |
|||||
|
(a) |
Name |
Hill & Smith Holdings PLC |
||||
|
(b) |
LEI |
2138003A3ISGQZBOWI83 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
(a) |
Description of the Financial Instrument |
Ordinary shares of £0.25 each |
||||
|
(b) |
Identification code of the Financial Instrument |
GB0004270301 |
||||
|
(c) |
Nature of the transaction |
Open Market Purchase |
||||
|
(d) |
Price(s) and volume(s) |
|
||||
|
(e) |
Aggregated information |
N/A single transaction |
||||
|
(f) |
Date of the transaction |
8 April 2022 |
||||
|
(g) |
Place of the transaction |
LON |
||||
Enquiries:
Alex Henderson
Company Secretary
0121 704 7430
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.